ResearcherYale New Haven Health SystemNo recent work listed

Casey G. Langdon

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-0010-7209; OpenAlex author ID A5026440661.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper

Papers 1

Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor. First author DOI 10.1158/1535-7163.mct-16-0794 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

David F. Stern · 1 shared paper, 2017
- Paper Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inh… DOI 10.1158/1535-7163.mct-16-0794 ↗
Howard S. Höchster · 1 shared paper, 2017
- Paper Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inh… DOI 10.1158/1535-7163.mct-16-0794 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.